GSK PLC/ GB00BN7SWP63 /
| 2024-04-26 5:35:30 PM | Chg. +14.00 | Volume | Bid5:35:30 PM | Ask5:45:40 PM | Market Capitalization | Dividend Y. | P/E Ratio |
|---|---|---|---|---|---|---|---|
| 1,654.50GBX | +0.85% | 311,380 Turnover(GBP): 5.12 mill. |
-Bid Size: - | -Ask Size: - | 66.58 bill.GBP | - | - |
GlobeNewswire
04-25
Nucleome Therapeutics appoints Dr John Davis as Non-Executive Director of the Board and establishes ...
GlobeNewswire
04-23
Wave Life Sciences Announces Continued Momentum in GSK Collaboration and Advancements in siRNA and R...
GlobeNewswire
04-22
Kynos Therapeutics announces positive top-line results from the first-in-human Phase I study of its ...
GlobeNewswire
04-10
Sitryx nominates SYX-5219 a novel, oral and targeted PKM2 activator for clinical development in atop...
GlobeNewswire
04-09
SCYNEXIS to Present Preclinical Data on Second Generation Fungerp SCY-247 at the 34th European Congr...
GlobeNewswire
04-08
Actuate Therapeutics Announces Poster Presentations at the 2024 AACR Annual Meeting
GlobeNewswire
04-08
OMass Therapeutics expands Scientific Advisory Board with the appointment of Sarah Teichmann
GlobeNewswire
04-04
Over 52 Million Myeloma Warriors Reached, Creating Ripples Across the Globe for #MyelomaACTIONMonth
GlobeNewswire
04-03
AAFA's Advocacy for Health Equity Leads to White House Address on Asthma Inhaler Pricing
GlobeNewswire
03-27
Algernon Pharmaceuticals Announces Closing of the Acquisition of its Chronic Cough Research Program ...
GlobeNewswire
03-21
LIXTE Provides Update on Progress with LB-100 as a PP2A Inhibitor to Enhance Chemotherapy and Immuno...
GlobeNewswire
03-21
Sosei Heptares Regains Full Ownership from GSK of HTL0027477, a Clinic-ready, First-in-Class Oral GP...
GlobeNewswire
03-18
Orchard Therapeutics Receives FDA Approval of Lenmeldy™ (atidarsagene autotemcel), the Only Therapy ...
GlobeNewswire
03-15
American Kidney Fund Announces 2024 Class of Corporate Members Providing Support in the Fight Agains...
GlobeNewswire
03-13
Spero Therapeutics Announces Fourth Quarter and Full Year 2023 Operating Results and Provides a Busi...
GlobeNewswire
03-11
Anaptys Announces Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update
GlobeNewswire
03-06
Wave Life Sciences Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business...
GlobeNewswire
03-06
iTeos Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Updates
GlobeNewswire
03-04
Sitryx Therapeutics makes key appointments to strengthen business operations and progress immunometa...
